BRCA1 and ovarian carcinoma: The European Society of Medical Oncology (ESMO) (Cardoso et al., 2019) and NCCN (Esteller et al., 2000) of the United States stated that prophylactic RRSO may significantly reduce the risk of BC and ovarian cancer in women with BRCA1 gene mutation after the completion of reproductive needs.